Lee, Jiyun

Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer. [electronic resource] - Cancer research and treatment Jan 2019 - 408-412 p. digital

Publication Type: Case Reports; Journal Article

2005-9256

10.4143/crt.2018.138 doi


Acrylamides
Aniline Compounds
Carcinoma, Non-Small-Cell Lung--drug therapy
Drug Resistance, Neoplasm
ErbB Receptors--genetics
Female
Gene Frequency
Humans
Lung Neoplasms--drug therapy
Middle Aged
Mutation
Piperazines--therapeutic use
Protein Kinase Inhibitors--therapeutic use
Republic of Korea